BIOMAT Database Logo BIOMAT Database Logo

Antiretroviral therapy: reverse transcriptase inhibition. 1992

K J Connolly, and S M Hammer
Department of Medicine, New England Deaconess Hospital, Boston, Massachusetts.

UI MeSH Term Description Entries
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D012192 Retroviridae Infections Virus diseases caused by the RETROVIRIDAE. Retrovirus Infections,Infections, Retroviridae,Infections, Retrovirus,XMRV Infection,Xenotropic MuLV-related Virus Infection,Xenotropic Murine Leukemia Virus-related Virus Infection,Infection, Retroviridae,Infection, Retrovirus,Infection, XMRV,Infections, XMRV,Retroviridae Infection,Retrovirus Infection,XMRV Infections,Xenotropic MuLV related Virus Infection,Xenotropic Murine Leukemia Virus related Virus Infection
D018894 Reverse Transcriptase Inhibitors Inhibitors of reverse transcriptase (RNA-DIRECTED DNA POLYMERASE), an enzyme that synthesizes DNA on an RNA template. Reverse Transcriptase Inhibitor,Inhibitors, Reverse Transcriptase,Inhibitor, Reverse Transcriptase,Transcriptase Inhibitor, Reverse

Related Publications

K J Connolly, and S M Hammer
[Antiretroviral therapy. NNRTI (non-nucleoside reverse transcriptase inhibitor)].
March 2000, MMW Fortschritte der Medizin,
K J Connolly, and S M Hammer
Mutation covariation of HIV-1 CRF07_BC reverse transcriptase during antiretroviral therapy.
November 2013, The Journal of antimicrobial chemotherapy,
K J Connolly, and S M Hammer
The emerging roles of non-nucleoside reverse transcriptase inhibitors in antiretroviral therapy.
January 2001, Drugs,
K J Connolly, and S M Hammer
Reverse transcriptase genotypes in pediatric patients failing initial antiretroviral therapy in Gaborone, Botswana.
January 2012, Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002),
K J Connolly, and S M Hammer
The role of nucleoside and nucleotide reverse transcriptase inhibitor backbones in antiretroviral therapy.
September 2004, Journal of acquired immune deficiency syndromes (1999),
K J Connolly, and S M Hammer
Discontinuation of non-nucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy due to nucleoside analogue reverse transcriptase inhibitor-related metabolic toxicity.
May 2007, International journal of STD & AIDS,
K J Connolly, and S M Hammer
Inhibition of reverse transcriptase by limocrocin.
June 1985, The Journal of antibiotics,
K J Connolly, and S M Hammer
New antiretroviral agents: looking beyond protease and reverse transcriptase.
October 2001, Current opinion in microbiology,
K J Connolly, and S M Hammer
Entecavir therapy induces de novo HIV reverse-transcriptase M184V mutation in an antiretroviral therapy-naive patient.
May 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
K J Connolly, and S M Hammer
Non-nucleoside reverse transcriptase inhibitor outcomes among combination antiretroviral therapy-treated adults in Botswana.
January 2010, AIDS (London, England),
Copied contents to your clipboard!